Should healthcare be a public good, a market product, or some hybrid — and who pays?
Each issue breaks into the specific questions Congress actually fights over. Read each position, then head to the interactive version of this issue to mark which reflects your view and build a message to your representatives.
Universal coverage is a moral imperative in a wealthy society. The ACA individual mandate was struck effectively when the penalty was zeroed out — leaving millions uninsured without a replacement mechanism.
Near-universal coverage is an achievable goal through a combination of Medicaid expansion, marketplace subsidies, and employer requirements. A mandate may not be necessary if subsidies are generous enough.
Forcing people to buy a product they don't want is an unconstitutional government overreach. People should be able to choose coverage appropriate to their needs and means.
A Medicare-for-All or robust public option would eliminate insurance company profit from healthcare, reduce administrative costs, and improve bargaining power on drug prices.
A public option competing with private insurance — rather than replacing it — gives consumers choice while introducing market pressure. It could serve as a path to broader coverage without disrupting existing coverage.
A public option backed by government subsidies will crowd out private insurance, eventually collapsing the market into single-payer — with consequences for innovation, wait times, and quality.
The U.S. pays 2-3× what other wealthy nations pay for the same drugs. Direct Medicare negotiation — as finally authorized in the IRA — is overdue and should be expanded.
Allowing Medicare to negotiate is a reasonable market intervention given its scale. Reference pricing to international benchmarks and faster generic approval also improve competition.
Price controls reduce pharmaceutical R&D investment — the engine of medical innovation. High U.S. prices effectively subsidize drug development that benefits the whole world.
10 states still have not expanded Medicaid under the ACA, leaving millions in a coverage gap — too rich for Medicaid, too poor for marketplace subsidies. Federal incentives should close this gap.
The ACA's Medicaid expansion has demonstrably improved coverage, particularly for rural and working-poor populations. Holdout states' taxpayers subsidize expansion elsewhere without receiving the benefit.
Medicaid expansion increases dependency, crowds out private coverage, and has shown mixed results on actual health outcomes. States should have flexibility in program design, not be pressured into a one-size-fits-all expansion.
Insurance market regulations — guaranteed issue, community rating, essential health benefits — are the core of the ACA and what made pre-existing condition protections real rather than theoretical.
Balanced risk pools require some combination of mandates, subsidies, and regulations. Short-term health plans that exempt young, healthy people undermine the pool for everyone else.
ACA market regulations drive up premiums for healthy people to subsidize others. Deregulation, association health plans, and health savings accounts give individuals more choices and lower costs.